Global SPECT Radiopharmaceuticals Market 2025 by Company, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global SPECT Radiopharmaceuticals market size was valued at US$ 5319 million in 2024 and is forecast to a readjusted size of USD 15170 million by 2031 with a CAGR of 16.3% during review period.
SPECT (Single Photon Emission Computed Tomography) radiopharmaceuticals are compounds that contain a radioactive isotope used in conjunction with SPECT imaging techniques. These radiopharmaceuticals emit gamma radiation, which is detected by a gamma camera during a SPECT scan, creating detailed 3D images of the internal structures and functions of the body. These radiopharmaceuticals are primarily used for diagnostic imaging, allowing healthcare providers to evaluate the function of organs, tissues, and systems without invasive procedures.
SPECT radiopharmaceuticals are a type of radioactive tracers used in nuclear medicine imaging that can help doctors detect heart disease, neurological diseases, cancer, bone diseases, and thyroid diseases. They rely on short-half-life radioisotopes to obtain physiological function information through SPECT scanners, and have important applications in modern medicine.
From a regional perspective, North America and Europe have advanced medical infrastructure and strong R&D capabilities. As the world's largest radiopharmaceutical market, they have promoted the widespread use of SPECT radiopharmaceuticals. The increase in medical demand in emerging markets such as Asia Pacific and Latin America will provide new growth momentum for the SPECT radiopharmaceutical market.
Global leading suppliers include GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, etc. The production of radiopharmaceuticals requires complex nuclear technology and strict safety supervision. These high technical barriers limit the entry of new companies and maintain the stability of the market.
With the advancement of medical technology, new radioisotopes and labeling methods will be developed to improve the accuracy and efficiency of SPECT imaging and promote market development.
This report is a detailed and comprehensive analysis for global SPECT Radiopharmaceuticals market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global SPECT Radiopharmaceuticals market size and forecasts, in consumption value ($ Million), 2020-2031
Global SPECT Radiopharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global SPECT Radiopharmaceuticals market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global SPECT Radiopharmaceuticals market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for SPECT Radiopharmaceuticals
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global SPECT Radiopharmaceuticals market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, Eczacibasi-Monrol, Siemens Healthineers, Bayer (Radiology Division), Molecular Imaging, Inc., NorthStar Medical Radioisotopes, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
SPECT Radiopharmaceuticals market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Technetium-99m (Tc-99m) Based Agents
Iodine-123 (I-123) Based Agents
Gallium-67 (Ga-67)
Indium-111 (In-111) Based Agents
Thallium-201 (Tl-201)
Market segment by Application
Cardiac Imaging
Cancer Imaging
Brain Imaging
Thyroid Imaging
Infection and Inflammation Imaging
Market segment by players, this report covers
GE Healthcare
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging
Curium Pharma
Eczacibasi-Monrol
Siemens Healthineers
Bayer (Radiology Division)
Molecular Imaging, Inc.
NorthStar Medical Radioisotopes
Advanced Accelerator Applications
IBA Molecular Imaging
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe SPECT Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of SPECT Radiopharmaceuticals, with revenue, gross margin, and global market share of SPECT Radiopharmaceuticals from 2020 to 2025.
Chapter 3, the SPECT Radiopharmaceuticals competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and SPECT Radiopharmaceuticals market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of SPECT Radiopharmaceuticals.
Chapter 13, to describe SPECT Radiopharmaceuticals research findings and conclusion.
SPECT (Single Photon Emission Computed Tomography) radiopharmaceuticals are compounds that contain a radioactive isotope used in conjunction with SPECT imaging techniques. These radiopharmaceuticals emit gamma radiation, which is detected by a gamma camera during a SPECT scan, creating detailed 3D images of the internal structures and functions of the body. These radiopharmaceuticals are primarily used for diagnostic imaging, allowing healthcare providers to evaluate the function of organs, tissues, and systems without invasive procedures.
SPECT radiopharmaceuticals are a type of radioactive tracers used in nuclear medicine imaging that can help doctors detect heart disease, neurological diseases, cancer, bone diseases, and thyroid diseases. They rely on short-half-life radioisotopes to obtain physiological function information through SPECT scanners, and have important applications in modern medicine.
From a regional perspective, North America and Europe have advanced medical infrastructure and strong R&D capabilities. As the world's largest radiopharmaceutical market, they have promoted the widespread use of SPECT radiopharmaceuticals. The increase in medical demand in emerging markets such as Asia Pacific and Latin America will provide new growth momentum for the SPECT radiopharmaceutical market.
Global leading suppliers include GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, etc. The production of radiopharmaceuticals requires complex nuclear technology and strict safety supervision. These high technical barriers limit the entry of new companies and maintain the stability of the market.
With the advancement of medical technology, new radioisotopes and labeling methods will be developed to improve the accuracy and efficiency of SPECT imaging and promote market development.
This report is a detailed and comprehensive analysis for global SPECT Radiopharmaceuticals market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global SPECT Radiopharmaceuticals market size and forecasts, in consumption value ($ Million), 2020-2031
Global SPECT Radiopharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global SPECT Radiopharmaceuticals market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global SPECT Radiopharmaceuticals market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for SPECT Radiopharmaceuticals
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global SPECT Radiopharmaceuticals market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, Eczacibasi-Monrol, Siemens Healthineers, Bayer (Radiology Division), Molecular Imaging, Inc., NorthStar Medical Radioisotopes, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
SPECT Radiopharmaceuticals market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Technetium-99m (Tc-99m) Based Agents
Iodine-123 (I-123) Based Agents
Gallium-67 (Ga-67)
Indium-111 (In-111) Based Agents
Thallium-201 (Tl-201)
Market segment by Application
Cardiac Imaging
Cancer Imaging
Brain Imaging
Thyroid Imaging
Infection and Inflammation Imaging
Market segment by players, this report covers
GE Healthcare
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging
Curium Pharma
Eczacibasi-Monrol
Siemens Healthineers
Bayer (Radiology Division)
Molecular Imaging, Inc.
NorthStar Medical Radioisotopes
Advanced Accelerator Applications
IBA Molecular Imaging
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe SPECT Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of SPECT Radiopharmaceuticals, with revenue, gross margin, and global market share of SPECT Radiopharmaceuticals from 2020 to 2025.
Chapter 3, the SPECT Radiopharmaceuticals competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and SPECT Radiopharmaceuticals market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of SPECT Radiopharmaceuticals.
Chapter 13, to describe SPECT Radiopharmaceuticals research findings and conclusion.
Table of Contents
119 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
- 10 Middle East & Africa
- 11 Market Dynamics
- 12 Industry Chain Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
